Abstract
Endothelial apoptosis triggered by oxidized low-density lipoprotein (oxLDL) can accelerate the progression of endothelial dysfunction atherosclerosis. Phosphocreatine (PCr) is a natural compound, which has been used in cardiac disease and cardiopulmonary resuscitation. However, its protective effects on atherosclerosis and its mechanism have not been clarified. In the present study, we investigated the anti-apoptotic effect of phosphocreatine in human umbilical vein endothelial cells (HUVECs) exposed to oxLDL and explored the possible mechanisms. HUVECs were pre-treated with 10–30 mM PCr and then stimulated with oxLDL. Cell morphology, cytotoxicity and apoptosis were evaluated by light microscopy, CCK assay, and flow cytometry respectively. Levels of Bax, Bcl-2, protein expression of protein kinase B (Akt), eNOS and caspase activities were assessed by Western blotting. Reactive oxygen species (ROS) and mitochondrial membrane potential (MMP) were measured with fluorescent probes. Lactate dehydrogenase (LDH), malondialdehyde (MDA), nitric oxide (NO) and superoxide dismutase (SOD) contents were determined by spectrophotometer. Our results showed that PCr dose-dependently prevented oxLDL associated HUVEC cytotoxicity and apoptotic biochemical changes such as loss of MMP, LDH and MDA leakage and loss of SOD, decrease of Bcl-2/Bax protein ratio, activation of caspase-3 and 9, and ROS generation. In addition, the antiapoptotic effect of PCr was partially inhibited by a PI3K inhibitor (LY294002) and also enhanced p-Akt/Akt protein ratio, eNOS activation and NO production. In conclusion, our data show that the inhibition of oxLDL-induced endothelial apoptosis by PCr is due, at least in part to its anti-oxidant activity and its ability to modulate the PI3K/Akt/eNOS signaling pathway.
Similar content being viewed by others
Abbreviations
- PCr:
-
Phosopho creatine
- oxLDL:
-
Oxidative low density lipoprotein
- FBS:
-
Fetal bovine serum
- HUVEC:
-
Human umbilical vein endothelial cell
- LDH:
-
Lactate dehydrogenase
- MDA:
-
Malondialdehyde
- SOD:
-
Superoxide dismutase
- ROS:
-
Reactive oxygen species
- MMP:
-
Mitochondrial membrane potential
- Akt:
-
Protein kinase B
- eNOS:
-
Endothelial nitric oxide synthase
- NO:
-
Nitric oxide
- NAC:
-
N-Acetyl cysteine
References
Weinberg PD (2004) Rate-limiting steps in the development of atherosclerosis: the response-to-influx theory. J Vasc Res 41(1):1–17
Ross R (1999) Atherosclerosis—an inflammatory disease. N Engl J Med 340(2):115–126
Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352(16):1685–1695
Steinberg D et al (1989) Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320(14):915–924
Napoli C (2003) Oxidation of LDL, atherogenesis, and apoptosis. Ann N Y Acad Sci 1010:698–709
Romano M et al (1998) Ultrastructural localization of secretory type II phospholipase A2 in atherosclerotic and nonatherosclerotic regions of human arteries. Arterioscler Thromb Vasc Biol 18(4):519–525
Auge N et al (1999) Role of sphingosine 1-phosphate in the mitogenesis induced by oxidized low density lipoprotein in smooth muscle cells via activation of sphingomyelinase, ceramidase, and sphingosine kinase. J Biol Chem 274(31):21533–21538
Salvayre R et al (2002) Oxidized low-density lipoprotein-induced apoptosis. Biochim Biophys Acta 1585(2–3):213–221
Cho BB, Toledo-Pereyra LH (2008) Caspase-independent programmed cell death following ischemic stroke. J Invest Surg 21(3):141–147
Fulton D et al (1999) Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399(6736):597–601
Datta SR, Brunet A, Greenberg ME (1999) Cellular survival: a play in three Akts. Genes Dev 13(22):2905–2927
Chavakis E et al (2001) Oxidized LDL inhibits vascular endothelial growth factor-induced endothelial cell migration by an inhibitory effect on the Akt/endothelial nitric oxide synthase pathway. Circulation 103(16):2102–2107
Huie RE, Padmaja S (1993) The reaction of no with superoxide. Free Radic Res Commun 18(4):195–199
Jaffe EA et al (1973) Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52(11):2745–2756
Spaet TH, Stemerman MB (1972) Platelet adhesion. Ann N Y Acad Sci 201:13–21
Stemerman MB, Spaet TH (1972) The subendothelium and thrombogenesis. Bull N Y Acad Med 48(2):289–301
Ohta MY et al (2000) Inhibitory effect of troglitazone on TNF-alpha-induced expression of monocyte chemoattractant protein-1 (MCP-1) in human endothelial cells. Diabetes Res Clin Pract 48(3):171–176
Fitch CD et al (1968) Creatine metabolism in skeletal muscle. 3. Specificity of the creatine entry process. J Biol Chem 243(8):2024–2027
Chambers DJ et al (1996) St. Thomas’ Hospital cardioplegia: enhanced protection with exogenous creatine phosphate. Ann Thorac Surg 61(1):67–75
Balestrino M et al (2002) Role of creatine and phosphocreatine in neuronal protection from anoxic and ischemic damage. Amino Acids 23(1–3):221–229
Wang CB et al (1995) Rapid isolation of large amount of plasma VLDL and LDL by a two step ultracentrifugation. J Tongji Med Univ 15(4):198–200
Aviram M, Vaya J (2001) Markers for low-density lipoprotein oxidation. Methods Enzymol 335:244–256
Amaravadi R, Thompson CB (2005) The survival kinases Akt and Pim as potential pharmacological targets. J Clin Invest 115(10):2618–2624
Mannarino E, Pirro M (2008) Molecular biology of atherosclerosis. Clin Cases Miner Bone Metab 5(1):57–62
Resch U et al (2006) Reduction of oxidative stress and modulation of autoantibodies against modified low-density lipoprotein after rosuvastatin therapy. Br J Clin Pharmacol 61(3):262–274
Chen CH et al (2000) Oxidized low-density lipoproteins inhibit endothelial cell proliferation by suppressing basic fibroblast growth factor expression. Circulation 101(2):171–177
Inoue M et al (2001) Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-gamma. Arterioscler Thromb Vasc Biol 21(4):560–566
Kuzuya M et al (2001) VEGF protects against oxidized LDL toxicity to endothelial cells by an intracellular glutathione-dependent mechanism through the KDR receptor. Arterioscler Thromb Vasc Biol 21(5):765–770
Jovinge S et al (1996) Human monocytes/macrophages release TNF-alpha in response to Ox-LDL. Arterioscler Thromb Vasc Biol 16(12):1573–1579
Erl W, Weber PC, Weber C (1998) Monocytic cell adhesion to endothelial cells stimulated by oxidized low density lipoprotein is mediated by distinct endothelial ligands. Atherosclerosis 136(2):297–303
Davignon J, Ganz P (2004) Role of endothelial dysfunction in atherosclerosis. Circulation 109(23 Suppl 1):iii27–iii32
Thorin-Trescases N et al (2005) Pathological aging of the vascular endothelium: are endothelial progenitor cells the sentinels of the cardiovascular system? Can J Cardiol 21(12):1019–1024
Sun J et al (2007) Mast cells promote atherosclerosis by releasing proinflammatory cytokines. Nat Med 13(6):719–724
Chen YH et al (2006) Anti-inflammatory effects of different drugs/agents with antioxidant property on endothelial expression of adhesion molecules. Cardiovasc Hematol Disord Drug Targets 6(4):279–304
Lander HM (1997) An essential role for free radicals and derived species in signal transduction. Faseb J 11(2):118–124
Chandel NS et al (2000) Role of oxidants in NF-kappa B activation and TNF-alpha gene transcription induced by hypoxia and endotoxin. J Immunol 165(2):1013–1021
Roebuck KA (1999) Oxidant stress regulation of IL-8 and ICAM-1 gene expression: differential activation and binding of the transcription factors AP-1 and NF-kappaB (review). Int J Mol Med 4(3):223–230
Droge W (2002) Free radicals in the physiological control of cell function. Physiol Rev 82(1):47–95
Gauthaman K et al (2001) Effect of chronic treatment with bark of Terminalia arjuna: a study on the isolated ischemic-reperfused rat heart. J Ethnopharmacol 75(2–3):197–201
Luo X et al (1998) Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94(4):481–490
Sugawara T et al (2004) Neuronal death/survival signaling pathways in cerebral ischemia. NeuroRx 1(1):17–25
Hockenbery D et al (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348(6299):334–336
Choy JC et al (2001) Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis. J Mol Cell Cardiol 33(9):1673–1690
Ly JD, Grubb DR, Lawen A (2003) The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update. Apoptosis 8(2):115–128
Dimmeler S et al (1999) Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399(6736):601–605
Achan V et al (2003) Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arterioscler Thromb Vasc Biol 23(8):1455–1459
Ignarro LJ et al (1999) Nitric oxide as a signaling molecule in the vascular system: an overview. J Cardiovasc Pharmacol 34(6):879–886
Napoli C et al (2006) Nitric oxide and atherosclerosis: an update. Nitric Oxide 15(4):265–279
Mannick JB et al (1999) Fas-induced caspase denitrosylation. Science 284(5414):651–654
Hoffmann J et al (2001) Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli: important role of nitric oxide. Circ Res 89(8):709–715
Acknowledgments
This work was supported by the Natural Science Foundation of China (No. 30772601) and the University Innovation Team Project Foundation of Education Department of Liaoning Province (No. LT2013019).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Authors have no conflict of interest.
Rights and permissions
About this article
Cite this article
Ahsan, A., Han, G., Pan, J. et al. Phosphocreatine protects endothelial cells from oxidized low-density lipoprotein-induced apoptosis by modulating the PI3K/Akt/eNOS pathway. Apoptosis 20, 1563–1576 (2015). https://doi.org/10.1007/s10495-015-1175-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10495-015-1175-4